| ALLR Market Cap History Table | ||||||||||||||||||||||||||||||
Below is a table of the ALLR market cap history going back to 11/14/2022:
Also see: ALLR Shares Outstanding History and ALLR YTD Return |
As of 5/15/2026 Allarity Therapeutics has a market cap of 21.48 million. Investors often follow the ALLR market cap history to compare the size of the company over time.
This page shows ALLR market capitalization trends over time, with 14 market cap datapoints presented, dating back to 11/14/2022.

| ALLR Market Cap History Table | ||||||||||||||||||||||||||||||
Below is a table of the ALLR market cap history going back to 11/14/2022:
Also see: ALLR Shares Outstanding History and ALLR YTD Return |
| ALLR Market Cap History Chart | |||||||||||||||||||||||||||||||
ALLR Historical Market Cap: +46.53% CAGR
Mouse over chart for data details
| |||||||||||||||||||||||||||||||
| ALLR Stock Price Chart |
| About Allarity Therapeutics Inc |
| Allarity Therapeutics is a biopharmaceutical company developing therapeutic candidates together with its proprietary DRP® companion diagnostics. Co.'s lead therapeutic candidate, dovitinib, is a selective inhibitor of several classes of tyrosine kinases, including fibroblast growth factor receptors and vascular endothelial growth factor receptor for the treatment of third line renal cell carcinoma in patients. Co.'s second therapeutic candidate is stenoparib and Co. is developing this candidate for the treatment of ovarian cancer. Co.'s third candidate is IXEMPRA® (ixabepilone), a selective microtubule inhibitor, which has been shown to interfere with cancer cell division. We show 14 historical shares outstanding datapoints in our ALLR shares outstanding history coverage, used to compute ALLR market cap on those dates. Understanding the changing numbers of shares outstanding, the changing share price, and the resulting changing ALLR market cap history over the course of time is important for investors interested in comparing ALLR's market cap history versus its peers. Many "beginner" or "novice" investors will look at one stock trading at a price of $10 per share and another trading at a price of $20 per share and think the latter company is worth twice as much. Of course, that is a completely meaningless comparison without also knowing how many shares outstanding there are for each of the two companies, and then calculating their respective market caps. Comparing the share price of ALLR versus a peer is one thing; comparing ALLR market cap versus a peer is a completely different story. Furthermore, via fluctuation both in per-share price and in the number of shares outstanding (via issuance of new shares over time, the repurchase of existing shares), the market cap for a company like ALLR can fluctuate over the course of history. With this page we aim to empower investors researching ALLR by allowing them to research the ALLR market cap history. |
| ALLR Current Stock Quote |
Quotes delayed 20 minutes Get Dividend Alerts Get SEC Filing Alerts |
| Video: The Importance of Market Cap | |
|
| ALLR Share Performance |
| Market Cap Peers |
| Allarity Therapeutics (ALLR) is categorized under the Healthcare sector; to help you further research historical market cap numbers, below are some other companies in the same sector:
ALMS Market Cap History ALNA Market Cap History ALNY Market Cap History ALOG Market Cap History ALPN Market Cap History ALQA Market Cap History ALRN Market Cap History ALT Market Cap History ALTS Market Cap History ALUR Market Cap History More Healthcare companies » |
Click the button below for your complimentary copy of Your Early Retirement Portfolio: Dividends Up to 8.7%—Every Month—Forever.
You'll discover the details on 4 stocks and funds that pay you massive dividends as high as 8.7%.